BRCA Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies

Medicina (Kaunas). 2021 Aug 30;57(9):905. doi: 10.3390/medicina57090905.


Background and Objectives:BRCA1 and BRCA2 are genes located in different chromosomes that are disproportionately associated with hereditary breast and ovarian cancer syndrome. Their association with other cancers remains to be explored. Materials and Methods: We systematically reviewed cohort studies to explore the association of BRCA 1 and BRCA2 with various cancers except lung cancer. We searched PubMed, Medline (EBSCOhost) and relevant articles published up to 10 May 2021. The odds ratio, standardised morbidity rate and cancer-specific standardised incidence ratio were pooled together as relative risk (RR) estimates. Results: Twelve studies were included for analysis. BRCA mutation increased pancreatic and uterine cancers by around 3-5- and 1.5-fold, respectively. BRCA mutation did not increase brain cancer; colorectal cancer; prostate, bladder and kidney cancer; cervical cancer; or malignant melanoma. BRCA2 increased gastric cancer with RR = 2.15 (1.98-2.33). Conclusion: The meta-analysis results can provide clinicians and relevant families with information regarding increased specific cancer risk in BRCA1 and BRCA2 mutation carriers.

Keywords: BRCA1; BRCA2; cancer; meta-analysis.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Breast Neoplasms*
  • Cohort Studies
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Humans
  • Lung Neoplasms*
  • Male
  • Mutation
  • Ovarian Neoplasms* / epidemiology
  • Ovarian Neoplasms* / genetics